← 產業報告目錄
Advanced Therapy Medicinal Products CDMO Market Size, Share & Trends Analysis Report By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others), By Phase, Indication, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-06頁數 180報告編號 INSIGHTACE-fa8ede5f35
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
A CAGR of 15.0% is forecasted for the global Advanced Therapy Medicinal Products CDMO Market over the assessment period of 2025 through 2034.
Advanced Therapy Medicinal Products CDMO covers key industry insights & findings from the report:
The demand for personalized treatment strategies represents a substantial driver for the advanced therapy medicinal products market. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is underpinned by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Advanced Therapy Medicinal Products CDMO Market Snapshot
Chapter 4. Global Advanced Therapy Medicinal Products CDMO Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Gene Therapy
5.2.2. Cell Therapy
5.2.3. Tissue Engineered
5.2.4. Others (Combined ATMPs, for example, biodegradable matric or scaffold)
Chapter 6. Market Segmentation 2: by Phase Estimates & Trend Analysis
6.1. by Phase & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Phase:
6.2.1. Phase I
6.2.2. Phase II
6.2.3. Phase III
6.2.4. Phase IV
Chapter 7. Market Segmentation 3: by Indication Estimates & Trend Analysis
7.1. by Indication & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Indication:
7.2.1. Oncology
7.2.2. Cardiology
7.2.3. Central Nervous System
7.2.4. Musculoskeletal
7.2.5. Infectious Disease
7.2.6. Dermatology
7.2.7. Endocrine, Metabolic, Genetic
7.2.8. Immunology & Inflammation
7.2.9. Ophthalmology
7.2.10. Hematology
7.2.11. Gastroenterology
7.2.12. Others
Chapter 8. Advanced Therapy Medicinal Products CDMO Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Advanced Therapy Medicinal Products CDMO Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.1.2. North America Advanced Therapy Medicinal Products CDMO Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
8.1.3. North America Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Indication, 2021-2034
8.1.4. North America Advanced Therapy Medicinal Products CDMO Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Product Type, 2021-2034
8.2.2. Europe Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Phase, 2021-2034
8.2.3. Europe Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Indication, 2021-2034
8.2.4. Europe Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Product Type, 2021-2034
8.3.2. Asia Pacific Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Phase, 2021-2034
8.3.3. Asia-Pacific Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Indication, 2021-2034
8.3.4. Asia Pacific Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Product Type, 2021-2034
8.4.2. Latin America Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Phase, 2021-2034
8.4.3. Latin America Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Indication, 2021-2034
8.4.4. Latin America Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Product Type, 2021-2034
8.5.2. Middle East & Africa Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Phase, 2021-2034
8.5.3. Middle East & Africa Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by Indication, 2021-2034
8.5.4. Middle East & Africa Advanced Therapy Medicinal Products CDMO Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Celonic
9.2.2. Bio Elpida
9.2.3. CGT Catapult
9.2.4. Rentschler Biopharma SE
9.2.5. AGC Biologics
9.2.6. Catalent
9.2.7. Lonza
9.2.8. WuXi Advanced Therapies
9.2.9. BlueReg
9.2.10. Minaris Regenerative Medicine
9.2.11. Patheon
9.2.12. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們